1. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

   PLCRC-MEDOCC group, Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R. & Koopman, M., 20-Aug-2020, In : BMC Cancer. 20, 1, 10 p., 790.

   Research output: Contribution to journal › Article › Academic › peer-review

2. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

   Qiu, S-Q., van Rooijen, J., Nienhuis, H. H., van der Vegt, B., Timmer-Bosscha, H., van Leeuwen-Stok, E., Walenkamp, A. M. E., van Deurzen, C. H. M., de Bock, G. H., de Vries, E. G. E. & Schroder, C. P., 18-Mar-2020, In : Breast cancer research. 22, 1, 10 p., 30.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Optimizing systemic therapy in metastatic breast cancer: implementation in daily practice and exploration of new drug targets

   van Rooijen, J., 2020, [Groningen]: Rijksuniversiteit Groningen. 144 p.

   Research output: Thesis › Thesis fully internal (DIV)

4. Immunotherapeutic options on the horizon in breast cancer treatment

   van Rooijen, J. M., Stutvoet, T. S., Schröder, C. P. & de Vries, E. G. E., Dec-2015, In : Pharmacology & Therapeutics. 156, p. 90-101 12 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (4) »